{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:08:35Z","timestamp":1769904515538,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.revmed.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T10:59:08Z","timestamp":1582541948000},"page":"390-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thyro\u00efdites\u00a0: o\u00f9 en est-on en 2019\u00a0?"],"prefix":"10.1016","volume":"41","author":[{"given":"A.","family":"Rouland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Buffier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Verg\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2020.02.003_bib0165","series-title":"Endotext [Internet]","article-title":"Acute and subacute, and Riedel's thyroiditis","author":"Shrestha","year":"2015"},{"issue":"26","key":"10.1016\/j.revmed.2020.02.003_bib0170","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Braverman LE: thyroiditis","volume":"348","author":"En","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.revmed.2020.02.003_bib0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/105072502753522428","article-title":"Acute suppurative thyroiditis caused by an infected piriform sinus fistula with thyrotoxicosis","volume":"12","author":"Fukata","year":"2002","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.revmed.2020.02.003_bib0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/thy.2008.0146","article-title":"Acute bacterial suppurative thyroiditis: a clinical review and expert opinion","volume":"20","author":"Paes","year":"2010","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.revmed.2020.02.003_bib0185","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2002-021799","article-title":"Clinical features and outcome of subacute thyroiditis in an incidence cohort: olmsted county, minnesota, study","volume":"88","author":"Fatourechi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2020.02.003_bib0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199607113350206","article-title":"Chronic autoimmune thyroiditis","volume":"335","author":"Daniels","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.revmed.2020.02.003_bib0195","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/jc.2014-2745","article-title":"Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis","volume":"100","author":"Lombardi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.revmed.2020.02.003_bib0200","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.revmed.2020.02.003_bib0205","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.revmed.2020.02.003_bib0210","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.revmed.2020.02.003_bib0215","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","author":"Eskes","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.revmed.2020.02.003_bib0220","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2004-0627","article-title":"Interferon-(-related thyroid disease: pathophysiological, epidemiological, and clinical aspects","volume":"89","author":"Carella","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.revmed.2020.02.003_bib0225","first-page":"49","article-title":"Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease","volume":"22","author":"Martocchia","year":"2001","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"10.1016\/j.revmed.2020.02.003_bib0230","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.1997.7.891","article-title":"Interferon-\u03b1-induced thyroid dysfunction: three clinical presentations and a review of the literature","volume":"7","author":"Koh","year":"1997","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.revmed.2020.02.003_bib0235","first-page":"132","article-title":"Interferon-alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis C","volume":"10","author":"Nadeem","year":"2010","journal-title":"Hepat Mon"},{"issue":"5","key":"10.1016\/j.revmed.2020.02.003_bib0240","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0002-9343(96)00259-8","article-title":"Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha","volume":"101","author":"Roti","year":"1996","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.revmed.2020.02.003_bib0245","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.revmed.2020.02.003_bib0250","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ando.2018.07.001","article-title":"Introduction to expert opinion on endocrine complications of new anticancer therapies","volume":"79","author":"Castinetti","year":"2018","journal-title":"Ann Endocrinol"},{"issue":"5","key":"10.1016\/j.revmed.2020.02.003_bib0255","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ando.2018.07.007","article-title":"Expert opinion on thyroid complications in immunotherapy","volume":"79","author":"Illouz","year":"2018","journal-title":"Ann Endocrinol"},{"issue":"2","key":"10.1016\/j.revmed.2020.02.003_bib0260","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/EJE-10-0833","article-title":"Thyroid autoimmunity and ophthalmopathy related to melanoma biologic therapy","volume":"164","author":"Min","year":"2011","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"issue":"2","key":"10.1016\/j.revmed.2020.02.003_bib0265","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/ERC-13-0499","article-title":"Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution","volume":"21","author":"Ryder","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"10.1016\/j.revmed.2020.02.003_bib0270","first-page":"4130","article-title":"Codon 17\u00a0polymorphism of the cytotoxic T lymphocyte antigen 4\u00a0gene in Hashimoto's thyroiditis and Addison's disease","volume":"82","author":"Donner","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.revmed.2020.02.003_bib0275","first-page":"143","article-title":"CTLA4\u00a0alanine-17\u00a0confers genetic susceptibility to Graves\u2019 disease and to type 1\u00a0diabetes mellitus","volume":"82","author":"Donner","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.revmed.2020.02.003_bib0280","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/ERC-18-0320","article-title":"French endocrine society guidance on endocrine side-effects of immunotherapy","volume":"26","author":"Castinetti","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.revmed.2020.02.003_bib0285","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ando.2018.07.003","article-title":"Expert opinion on thyroid complications of new anti-cancer therapies: tyrosine kinase inhibitors","volume":"79","author":"Drui","year":"2018","journal-title":"Ann Endocrinol"},{"issue":"3","key":"10.1016\/j.revmed.2020.02.003_bib0290","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.beem.2017.04.012","article-title":"Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients","volume":"31","author":"Resteghini","year":"2017","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.revmed.2020.02.003_bib0295","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1210\/jc.2009-2507","article-title":"Sorafenib-induced hypothyroidism is associated with increased type 3\u00a0deiodination","volume":"95","author":"Abdulrahman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.revmed.2020.02.003_bib0300","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/thy.2005.15.1177","article-title":"Postpartum thyroiditis: long-term follow-up","volume":"15","author":"Lucas","year":"2005","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.revmed.2020.02.003_bib0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2265.2010.03797.x","article-title":"Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction","volume":"73","author":"Stuckey","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.revmed.2020.02.003_bib0310","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/archinte.1990.00390190063008","article-title":"How common is postpartum thyroiditis? A methodologic overview of the literature","volume":"150","author":"Gerstein","year":"1990","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.revmed.2020.02.003_bib0315","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/09513599909167567","article-title":"Prevalence of pregnancy and postpartum thyroid dysfunction in a homogeneous population of Spain","volume":"13","author":"Garc\u00eda-Mayor","year":"1999","journal-title":"Gynecol Endocrinol"},{"issue":"4573","key":"10.1016\/j.revmed.2020.02.003_bib0160","first-page":"93","article-title":"Lassitude, coldness, and hair changes following pregnancy, and their response to treatment with thyroid extract","volume":"2","author":"Robertson","year":"1948","journal-title":"Br Med J"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886632030045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886632030045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:42:31Z","timestamp":1759336951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886632030045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S024886632030045X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2020.02.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyro\u00efdites\u00a0: o\u00f9 en est-on en 2019\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}